Correlation Between Dyne Therapeutics and Charles River

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Charles River at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Charles River into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Charles River Laboratories, you can compare the effects of market volatilities on Dyne Therapeutics and Charles River and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Charles River. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Charles River.

Diversification Opportunities for Dyne Therapeutics and Charles River

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Dyne and Charles is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Charles River Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Charles River Labora and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Charles River. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Charles River Labora has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Charles River go up and down completely randomly.

Pair Corralation between Dyne Therapeutics and Charles River

Considering the 90-day investment horizon Dyne Therapeutics is expected to under-perform the Charles River. In addition to that, Dyne Therapeutics is 3.41 times more volatile than Charles River Laboratories. It trades about -0.15 of its total potential returns per unit of risk. Charles River Laboratories is currently generating about -0.25 per unit of volatility. If you would invest  18,791  in Charles River Laboratories on November 9, 2024 and sell it today you would lose (2,164) from holding Charles River Laboratories or give up 11.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Dyne Therapeutics  vs.  Charles River Laboratories

 Performance 
       Timeline  
Dyne Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Charles River Labora 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Charles River Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in March 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Dyne Therapeutics and Charles River Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dyne Therapeutics and Charles River

The main advantage of trading using opposite Dyne Therapeutics and Charles River positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Charles River can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Charles River will offset losses from the drop in Charles River's long position.
The idea behind Dyne Therapeutics and Charles River Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Valuation
Check real value of public entities based on technical and fundamental data